viral diagnostic test kits market, viral diagnostic test kits market overview, global viral diagnostic test kits market, viral diagnostic test kits market players, viral diagnostic test kits market size, viral diagnostic test kits market outlook
What are the recent trends in market size and growth for the viral diagnostic test kits market?
The viral diagnostic test kits market size has grown strongly in recent years. It will grow from $16.26 billion in 2024 to $17.62 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to increasing healthcare expenditure, increasing global travel, a rise in chronic viral infections, a rise in demand for home testing kits, and growth in personalized medicine.
The viral diagnostic test kits market size is expected to see strong growth in the next few years. It will grow to $23.99 billion in 2029 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to increasing Ebola virus infections, increasing hemorrhagic fever, rising prevalence of viral infections, increasing prevalence of respiratory syncytial virus, and increasing prevalence of hepatitis. Major trends in the forecast period include technological advancements, point-of-care testing, AI and data analytics, integration with digital health records, and next-generation sequencing.
Get Your Free Sample of The Global Viral Diagnostic Test Kits Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16821&type=smp
How have varous drivers impacted the growth of the viral diagnostic test kits market?
The rising prevalence of viral infections is expected to propel the growth of the viral diagnostic test kits market going forward. Viral infections are caused by microscopic viruses that invade host cells, replicate within them, and can lead to a broad spectrum of symptoms ranging from mild to severe across different body parts. The incidence of viral infections is increasing due to global travel, urbanization, climate change influencing vector-borne diseases, and evolving viral strains that can cause new outbreaks or expand into new geographical regions. Viral diagnostic test kits are instrumental in identifying and confirming the presence of specific viral infections in patients by detecting viral nucleic acids (RNA or DNA), antigens, or antibodies in biological samples such as blood, saliva, or nasal swabs. For instance, according to the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, in 2022, there were 2,126 new cases of acute hepatitis B reported, alongside 16,729 newly reported cases of chronic hepatitis B. Further, in the period, 14 jurisdictions in the US reported rates of acute hepatitis B higher than the national average in the United States. Therefore, the rising prevalence of viral infections is driving the growth of the viral diagnostic test kits market.
What are the primary segments of the viral diagnostic test kits market?
The viral diagnostic test kits market covered in this report is segmented –
1) By Test: Traditional Tests, Rapid Test
2) By Test Type: Direct Fluorescent Antibody (DFA) Test, Immunochromatographic Assay, Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) Based Test, Agglutination Assay, Solid Phase Assay, Flow Through Assay, Other Test Types
3) By End-User: Research Laboratories, Clinics, Hospitals, Other End Users
Subsegments:
1) By Traditional Tests: Enzyme-Linked Immunosorbent Assay (ELISA), Polymerase Chain Reaction (PCR) Tests, Western Blot, Viral Culture Testing
2) By Rapid Test: Lateral Flow Assays (LFA), Immunochromatographic Strip Tests, Reverse Transcription Loop-Mediated Isothermal Amplification (RT-LAMP), Rapid Antigen Tests
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/viral-diagnostic-test-kits-global-market-report
Which firms are leading the viral diagnostic test kits market?
Major companies operating in the viral diagnostic test kits market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Quest Diagnostics Incorporated, Grifols S.A., Hologic Inc., PerkinElmer Inc., bioMérieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Ortho Clinical Diagnostics, Myriad Genetics Inc., Seegene Inc., OraSure Technologies Inc., Meridian Bioscience Inc., DiaSorin S.p.A., Trinity Biotech plc, Biodesix Inc.
How will industry trends affect the trajectory of the viral diagnostic test kits market?
Major companies operating in the viral diagnostic test kits market are developing innovative products, such as virus detection kit to sustain their position in the market. A virus detection kit refers to a diagnostic tool designed to identify the presence of specific viruses in biological samples, providing rapid and accurate results for effective disease monitoring and management. For instance, in August 2024, BlueStain Global Ltd, a UK-based company, launched MPox virus detection kit. The Bluestain MPox virus detection kit is a rapid diagnostic test designed to detect the mpox virus with high speed and accuracy, delivering results in just 15 to 30 minutes. This innovative kit is intended to enhance public health responses by facilitating early detection and containment of mpox outbreaks, particularly in resource-limited settings.
Which geographic trends are shaping the viral diagnostic test kits market, and which region has the highest market share?
North America was the largest region in the viral diagnostic test kits market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral diagnostic test kits market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Viral Diagnostic Test Kits Market Report 2025 Offer?
The viral diagnostic test kits market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Viral diagnostic test kits are medical devices or tools used to detect the presence of viral infections in clinical samples taken from patients. These kits typically contain reagents, antibodies, or other substances interacting with specific viral antigens or genetic material to produce a measurable signal. The tests can identify the presence of viral particles, antigens, or genetic material (like RNA or DNA) in samples such as blood, saliva, nasal swabs, or other bodily fluids.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16821
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
